Modern cancer treatments have substantially improved cure rates and have generated a great interest in and need for proper statistical tools to analyze survival data with non-negligible cure fractions. Data with cure fractions are often complicated by dependent censoring, and the analysis of this type of data typically involves untestable parametric assumptions on the dependence of the censorin...
